Eastern Cape Province Has High Levels Of Resistance To Injectable Second-Line Drugs In Patients Starting Treatment For MDR-TB

被引：0
|
作者：
Kvasnovsky, C.
Odendaal, R.
Brand, J.
Lancaster, J.
Dalton, T.
Wolfgang, M.
van der Walt, M.
Ershova, J.
Cegielski, J. P.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4034
引用
收藏
页数：1
相关论文
共 23 条
  • [1] Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB
    Hwang, S. S.
    Kim, H-R.
    Kim, H. J.
    Kim, M. J.
    Lee, S. M.
    Yoo, C-G.
    Kim, Y. W.
    Han, S. K.
    Shim, Y-S.
    Yim, J-J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (03) : 581 - 585
  • [2] Impact of second-line drug resistance on tuberculosis treatment outcomes in the United States: MDR-TB is bad enough
    Althomsons, S. P.
    Cegielski, J. P.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (10) : 1331 - 1334
  • [3] Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study
    Workineh Shibeshi
    Anandi N. Sheth
    Addisu Admasu
    Alemseged Beyene Berha
    Zenebe Negash
    Getnet Yimer
    [J]. BMC Pharmacology and Toxicology, 20
  • [4] Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study
    Shibeshi, Workineh
    Sheth, Anandi N.
    Admasu, Addisu
    Berha, Alemseged Beyene
    Negash, Zenebe
    Yimer, Getnet
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (1):
  • [5] Role of second-line injectable antituberculosis drugs in the treatment of MDR/XDR tuberculosis
    Quenard, Fanny
    Fournier, Pierre Edouard
    Drancourt, Michel
    Brouqui, Philippe
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 (02) : 252 - 254
  • [6] Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh
    Rahman, S. M. Mazidur
    Nasrin, Rumana
    Rahman, Arfatur
    Ahmed, Shahriar
    Khatun, Razia
    Uddin, Mohammad Khaja Mafij
    Rahman, Md. Mojibur
    Banu, Sayera
    [J]. PLOS ONE, 2021, 16 (12):
  • [7] Association Of Previously Treated Tuberculosis Using Second Line Tb Drugs With Conversion Rate Of Multi Drugs Resistance (mdr-Tb) Patients In Indonesia
    Handayani, D.
    Librianty, N.
    Soepandi, P. Z.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [8] MDR-TB Resistant to a Fluoroquinolone and Streptomycin but Susceptible to Second-Line Injectables Has Better Prognosis Than XDR-TB
    Chan, E. D.
    Strand, M. J.
    Iseman, M. D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [9] High prevalence of resistance to second-line anti-TB drugs
    [J]. Reactions Weekly, 2012, 1418 (1) : 4 - 4
  • [10] Resistance to fluoroquinolones and second-Line injectable drugs: impact on multidrug-resistant TB outcomes
    Falzon, Dennis
    Gandhi, Neel
    Migliori, Giovanni B.
    Sotgiu, Giovanni
    Cox, Helen S.
    Holtz, Timothy H.
    Hollm-Delgado, Maria-Graciela
    Keshavjee, Salmaan
    DeRiemer, Kathryn
    Centis, Rosella
    D'Ambrosio, Lia
    Lange, Christoph G.
    Bauer, Melissa
    Menzies, Dick
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (01) : 156 - 168
123